Teva's CGRP Migraine Med Hits a Stumbling Block Post author:Sam Post published:February 8, 2018 Post category:BioPharma It’s starting to feel like Teva can’t catch a break. Source: BioSpace You Might Also Like Argentum And Eli Lilly Settle Patent Dispute Over CIALIS August 22, 2017 How This CRISPR Biotech Could Make Investors Rich December 26, 2017 Stada Names Novartis Exec as New CEO, It's Fifth Leader Since 2016 January 31, 2018
